Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery

Molecular and Cellular Proteomics

Volumn 14, Issue 6, 2015, Pages 1616-1629

  Campos, Diana ^a,b   Freitas, Daniela ^b   Gomes, Joana ^b   Magalhães, Ana ^b   Steentoft, Catharina ^a   Gomes, Catarina ^b   Vester Christensen, Malene B ^a,f   Ferreira, José Alexandre ^c,d   Afonso, Luis P ^c   Santos, Lúcio L ^c   De Sousa, João Pinto ^e   Mandel, Ulla ^a   Clausen, Henrik ^a   Vakhrushev, Sergey Y ^a   Reis, Celso A ^b,e  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF PORTO   (Portugal)

^c PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^d UNIVERSITY OF AVEIRO   (Portugal)

^e University of Porto   (Portugal)

^f NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DICKKOPF 1 PROTEIN; GLYCOPROTEIN; HERMES ANTIGEN; LECTIN; N ACETYLGALACTOSAMINYLTRANSFERASE; PLASMA PROTEIN; POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE 5; SYNDECAN 1; TN ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; PROTEOME;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVE SITE; FEMALE; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOLOGY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEOMICS; STOMACH CARCINOMA; BLOOD; METABOLISM; MIDDLE AGED; STOMACH TUMOR; TUMOR CELL LINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CELL LINE, TUMOR; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; N-ACETYLGALACTOSAMINYLTRANSFERASES; PROTEOME; STOMACH NEOPLASMS;

EID: 84930470850     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M114.046862     Document Type: Article

References (70)

1. Surinova, S., Schiess, R., Huttenhain, R., Cerciello, F., Wollscheid, B., and Aebersold, R. (2011) On the development of plasma protein biomarkers. J. Proteome Res. 10, 5-16
2. Reis, C. A., Osorio, H., Silva, L., Gomes, C., and David, L. (2010) Alterations in glycosylation as biomarkers for cancer detection. J. Clin. Pathol. 63, 322-329
3. Drake, P. M., Cho, W., Li, B., Prakobphol, A., Johansen, E., Anderson, N. L., Regnier, F. E., Gibson, B. W., and Fisher, S. J. (2010) Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin. Chem. 56, 223-236
4. Chen, K., Gentry-Maharaj, A., Burnell, M., Steentoft, C., Marcos-Silva, L., Mandel, U., Jacobs, I., Dawnay, A., Menon, U., and Blixt, O. (2013) Microarray glycoprofiling of CA125 improves differential diagnosis of ovarian cancer. J. Proteome Res. 12, 1408-1418
5. Springer, G. F. (1984) T and Tn, general carcinoma autoantigens. Science 224, 1198-1206
6. Wahrenbrock, M. G., and Varki, A. (2006) Multiple hepatic receptors cooperate to eliminate secretory mucins aberrantly entering the bloodstream: are circulating cancer mucins the "tip of the iceberg?" Cancer Res. 66, 2433-2441
7. Wandall, H. H., Blixt, O., Tarp, M. A., Pedersen, J. W., Bennett, E. P., Mandel, U., Ragupathi, G., Livingston, P. O., Hollingsworth, M. A., Taylor-Papadimitriou, J., Burchell, J., and Clausen, H. (2010) Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res. 70, 1306-1313
8. Magnani, J. L., Nilsson, B., Brockhaus, M., Zopf, D., Steplewski, Z., Koprowski, H., and Ginsburg, V. (1982) A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J. Biol. Chem. 257, 14365-14369
9. Guadagni, F., Roselli, M., Amato, T., Cosimelli, M., Mannella, E., Tedesco, M., Grassi, A., Casale, V., Cavaliere, F., Greiner, J. W., and Schlom J. Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patients. J. Surg. Oncol. 2, 16-20
10. Guadagni, F., Roselli, M., Cosimelli, M., Mannella, E., Tedesco, M., Cavaliere, F., Grassi, A., Abbolito, M. R., Greiner, J. W., and Schlom, J. (1993) TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer. Cancer 72, 2098-2106
11. Kjeldsen, T., Clausen, H., Hirohashi, S., Ogawa, T., Iijima, H., and Hakomori, S. (1988) Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2-6 alpha- N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res. 48, 2214-2220
12. Baldus, S. E., and Hanisch, F. G. (2000) Biochemistry and pathological importance of mucin-associated antigens in gastrointestinal neoplasia. Adv. Cancer Res. 79, 201-248
13. Itzkowitz, S. H., Bloom, E. J., Kokal, W. A., Modin, G., Hakomori, S., and Kim, Y. S. (1990) Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 66, 1960-1966
14. Kobayashi, H., Terao, T., and Kawashima, Y. (1992) Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer. J. Clin. Oncol. 10, 95-101
15. Leivonen, M., Nordling, S., Lundin, J., von Boguslawski, K., and Haglund, C. (2001) STn and prognosis in breast cancer. Oncology 61, 299-305
16. Kim, G. E., Bae, H. I., Park, H. U., Kuan, S. F., Crawley, S. C., Ho, J. J., and Kim, Y. S. (2002) Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. Gastroenterology 123, 1052-1060
17. Ferreira, J. A., Videira, P. A., Lima, L., Pereira, S., Silva, M., Carrascal, M., Severino, P. F., Fernandes, E., Almeida, A., Costa, C., Vitorino, R., Amaro, T., Oliveira, M. J., Reis, C. A., Dall'Olio, F., Amado, F., and Santos, L. L. (2013) Overexpression of tumor-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours. Mol. Oncol. 7, 719-731
18. Cao, Y., Stosiek, P., Springer, G. F., and Karsten, U. (1996) Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study. Histochem. Cell Biol. 106, 197-207
19. Miles, D. W., Happerfield, L. C., Smith, P., Gillibrand, R., Bobrow, L. G., Gregory, W. M., and Rubens, R. D. (1994) Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer. Br. J. Cancer 70, 1272-1275
20. Gomes, C., Almeida, A., Ferreira, J. A., Silva, L., Santos-Sousa, H., Pintode-Sousa, J., Santos, L. L., Amado, F., Schwientek, T., Levery, S. B., Mandel, U., Clausen, H., David, L., Reis, C. A., and Osorio, H. (2013) Glycoproteomic analysis of serum from patients with gastric precancerous lesions. J. Proteome Res. 12, 1454-1466
21. Marcos, N. T., Bennett, E. P., Gomes, J., Magalhaes, A., Gomes, C., David, L., Dar, I., Jeanneau, C., DeFrees, S., Krustrup, D., Vogel, L. K., Kure, E. H., Burchell, J., Taylor-Papadimitriou, J., Clausen, H., Mandel, U., and Reis, C. A. (2011) ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues. Front. Biosci. 3, 1443-1455
22. Marcos, N. T., Pinho, S., Grandela, C., Cruz, A., Samyn-Petit, B., Harduin-Lepers, A., Almeida, R., Silva, F., Morais, V., Costa, J., Kihlberg, J., Clausen, H., and Reis, C. A. (2004) Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen. Cancer Res. 64, 7050-7057
23. Sewell, R., Backstrom, M., Dalziel, M., Gschmeissner, S., Karlsson, H., Noll, T., Gatgens, J., Clausen, H., Hansson, G. C., Burchell, J., and Taylor-Papadimitriou, J. (2006) The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumorassociated sialyl-Tn O-glycan in human breast cancer. J. Biol. Chem. 281, 3586-3594
24. Ju, T., Lanneau, G. S., Gautam, T., Wang, Y., Xia, B., Stowell, S. R., Willard, M. T., Wang, W., Xia, J. Y., Zuna, R. E., Laszik, Z., Benbrook, D. M., Hanigan, M. H., and Cummings, R. D. (2008) Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer Res. 68, 1636-1646
25. Radhakrishnan, P., Dabelsteen, S., Madsen, F. B., Francavilla, C., Kopp, K. L., Steentoft, C., Vakhrushev, S. Y., Olsen, J. V., Hansen, L., Bennett, E. P., Woetmann, A., Yin, G., Chen, L., Song, H., Bak, M., Hlady, R. A., Peters, S. L., Opavsky, R., Thode, C., Qvortrup, K., Schjoldager, K. T., Clausen, H., Hollingsworth, M. A., and Wandall, H. H. (2014) Immature truncated O-glycophenotype of cancer directly induces oncogenic features. Proc. Natl. Acad. Sci. U.S.A. 111, E4066-4075
26. Steentoft, C., Vakhrushev, S. Y., Vester-Christensen, M. B., Schjoldager, K. T., Kong, Y., Bennett, E. P., Mandel, U., Wandall, H., Levery, S. B., and Clausen, H. (2011) Mining the O-glycoproteome using zinc-finger nuclease- glycoengineered SimpleCell lines. Nat. Methods 8, 977-982
27. Gill, D. J., Tham, K. M., Chia, J., Wang, S. C., Steentoft, C., Clausen, H., Bard-Chapeau, E. A., and Bard, F. A. (2013) Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness. Proc. Natl. Acad. Sci. U.S.A. 110, E3152-3161
28. Steentoft, C., Vakhrushev, S. Y., Joshi, H. J., Kong, Y., Vester-Christensen, M. B., Schjoldager, K. T., Lavrsen, K., Dabelsteen, S., Pedersen, N. B., Marcos-Silva, L., Gupta, R., Bennett, E. P., Mandel, U., Brunak, S., Wandall, H. H., Levery, S. B., and Clausen, H. (2013) Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J. 32, 1478-1488
29. Schjoldager, K. T., Vakhrushev, S. Y., Kong, Y., Steentoft, C., Nudelman, A. S., Pedersen, N. B., Wandall, H. H., Mandel, U., Bennett, E. P., Levery, S. B., and Clausen, H. (2012) Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells. Proc. Natl. Acad. Sci. U.S.A. 109, 9893-9898
30. Steentoft, C., Bennett, E. P., Schjoldager, K. T., Vakhrushev, S. Y., Wandall, H. H., and Clausen, H. (2014) Precision genome editing: a small revolution for glycobiology. Glycobiology 24, 663-680
31. Lauren, P. (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. an attempt at a histoclinical classification. Acta Pathol. Microbiol. Scand. 64, 31-49
32. Adamczyk, B., Struwe, W. B., Ercan, A., Nigrovic, P. A., and Rudd, P. M. (2013) Characterization of fibrinogen glycosylation and its importance for serum/plasma N-glycome analysis. J. Proteome Res. 12, 444-454
33. Yang, Z., Halim, A., Narimatsu, Y., Joshi, H. J., Steentoft, C., Schjoldager, K. T., Schulz, M. A., Sealover, N. R., Kayser, K. J., Bennett, E. P., Levery, S. B., Vakhrushev, S. Y., and Clausen, H. (2014) The GalNAc-type O-glycoproteome of CHO cells characterized by the SimpleCell strategy. Mol. Cell. Proteomics 13, 3224-3235
34. Chalkley, R. J., Thalhammer, A., Schoepfer, R., and Burlingame, A. L. (2009) Identification of protein O-GlcNAcylation sites using electron transfer dissociation mass spectrometry on native peptides. Proc. Natl. Acad. Sci. U.S.A. 106, 8894-8899
35. Darula, Z., and Medzihradszky, K. F. (2009) Affinity enrichment and characterization of mucin core-1 type glycopeptides from bovine serum. Mol. Cell. Proteomics 8, 2515-2526
36. Marcos, N. T., Cruz, A., Silva, F., Almeida, R., David, L., Mandel, U., Clausen, H., Von Mensdorff-Pouilly, S., and Reis, C. A. (2003) Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines. J. Histochem. Cytochem. 51, 761-771
37. Mandel, U., Hassan, H., Therkildsen, M. H., Rygaard, J., Jakobsen, M. H., Juhl, B. R., Dabelsteen, E., and Clausen, H. (1999) Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family. Glycobiology 9, 43-52
38. Conze, T., Carvalho, A. S., Landegren, U., Almeida, R., Reis, C. A., David, L., and Soderberg, O. (2010) MUC2 mucin is a major carrier of the cancer-associated sialyl-Tn antigen in intestinal metaplasia and gastric carcinomas. Glycobiology 20, 199-206
39. Reis, C. A., David, L., Nielsen, P. A., Clausen, H., Mirgorodskaya, K., Roepstorff, P., and Sobrinho-Simoes, M. (1997) Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int. J. Cancer 74, 112-121
40. Larsson, L. I. (2000) Developmental biology of gastrin and somatostatin cells in the antropyloric mucosa of the stomach. Microsc. Res. Tech. 48, 272-281
41. Anderson, N. L., and Anderson, N. G. (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1, 845-867
42. States, D. J., Omenn, G. S., Blackwell, T. W., Fermin, D., Eng, J., Speicher, D. W., and Hanash, S. M. (2006) Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat. Biotechnol. 24, 333-338
43. da Cunha, C. B., Oliveira, C., Wen, X., Gomes, B., Sousa, S., Suriano, G., Grellier, M., Huntsman, D. G., Carneiro, F., Granja, P. L., and Seruca, R. (2010) De novo expression of CD44 variants in sporadic and hereditary gastric cancer. Lab. Invest. 90, 1604-1614
44. Paulson, J. C., and Colley, K. J. (1989) Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J. Biol. Chem. 264, 17615-17618
45. Gill, D. J., Chia, J., Senewiratne, J., and Bard, F. (2010) Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes. J. Cell Biol. 189, 843-858
46. Gill, D. J., Clausen, H., and Bard, F. (2011) Location, location, location: new insights into O-GalNAc protein glycosylation. Trends Cell Biol. 21, 149-158
47. Cancer Genome Atlas Research, N. (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202-209
48. Pinho, S. S., Carvalho, S., Marcos-Pinto, R., Magalhaes, A., Oliveira, C., Gu, J., Dinis-Ribeiro, M., Carneiro, F., Seruca, R., and Reis, C. A. (2013) Gastric cancer: adding glycosylation to the equation. Trends Mol. Med. 19, 664-676
49. Smolen, G. A., Sordella, R., Muir, B., Mohapatra, G., Barmettler, A., Archibald, H., Kim, W. J., Okimoto, R. A., Bell, D. W., Sgroi, D. C., Christensen, J. G., Settleman, J., and Haber, D. A. (2006) Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752. Proc. Natl. Acad. Sci. U.S.A. 103, 2316-2321
50. Levery, S. B., Steentoft, C., Halim, A., Narimatsu, Y., Clausen, H., and Vakhrushev, S. Y. (2014) Advances in mass spectrometry driven Oglycoproteomics. Biochim. Biophys. Acta pii: S0304-4165(14)00328-6
51. Steentoft, C., Bennett, E. P., and Clausen, H. (2013) Glycoengineering of human cell lines using zinc finger nuclease gene targeting: SimpleCells with homogeneous GalNAc O-glycosylation allow isolation of the Oglycoproteome by one-step lectin affinity chromatography. Methods Mol. Biol. 1022, 387-402
52. Darula, Z., Sherman, J., and Medzihradszky, K. F. (2012) How to dig deeper? Improved enrichment methods for mucin core-1 type glycopeptides. Mol. Cell Proteomics 11, O111 016774
53. Kim, D. H., Oh, S. J., Oh, C. A., Choi, M. G., Noh, J. H., Sohn, T. S., Bae, J. M., and Kim, S. (2011) The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy. J. Surg. Oncol. 104, 585-591
54. Marrelli, D., Roviello, F., De Stefano, A., Farnetani, M., Garosi, L., Messano, A., and Pinto, E. (1999) Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 57, 55-62
55. Gbormittah, F. O., Haab, B. B., Partyka, K., Garcia-Ott, C., Hancapie, M., and Hancock, W. S. (2014) Characterization of glycoproteins in pancreatic cyst fluid using a high-performance multiple lectin affinity chromatography platform. J. Proteome Res. 13, 289-299
56. Haab, B. B., Partyka, K., and Cao, Z. (2013) Using antibody arrays to measure protein abundance and glycosylation: considerations for optimal performance. Curr. Protoc. Protein Sci. 73, Unit 27.6
57. Li, C., Simeone, D. M., Brenner, D. E., Anderson, M. A., Shedden, K. A., Ruffin, M. T., and Lubman, D. M. (2009) Pancreatic cancer serum detection using a lectin/glyco-antibody array method. J. Proteome Res. 8, 483-492
58. Zhao, J., Simeone, D. M., Heidt, D., Anderson, M. A., and Lubman, D. M. (2006) Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum. J. Proteome Res. 5, 1792-1802
59. Motoo, Y., Kawakami, H., Watanabe, H., Satomura, Y., Ohta, H., Okai, T., Makino, H., Toya, D., and Sawabu, N. (1991) Serum sialyl-Tn antigen levels in patients with digestive cancers. Oncology 48, 321-326
60. Nanashima, A., Yamaguchi, H., Nakagoe, T., Matsuo, S., Sumida, Y., Tsuji, T., Sawai, T., Yamaguchi, E., Yasutake, T., and Ayabe, H. (1999) High serum concentrations of sialyl Tn antigen in carcinomas of the biliary tract and pancreas. J. Hepatobiliary Pancreat. Surg. 6, 391-395
61. Takahashi, I., Maehara, Y., Kusumoto, T., Yoshida, M., Kakeji, Y., Kusumoto, H., Furusawa, M., and Sugimachi, K. (1993) Predictive value of preoperative serum sialyl Tn antigen levels in prognosis of patients with gastric cancer. Cancer 72, 1836-1840
62. Nakagoe, T., Sawai, T., Tsuji, T., Jibiki, M., Nanashima, A., Yamaguchi, H., Kurosaki, N., Yasutake, T., Ayabe, H., and Tagawa, Y. (2000) Prognostic value of circulating sialyl Tn antigen in colorectal cancer patients. Anticancer Res. 20, 3863-3869
63. Nakagoe, T., Sawai, T., Tsuji, T., Jibiki, M., Nanashima, A., Yamaguchi, H., Yasutake, T., Ayabe, H., Arisawa, K., and Ishikawa, H. (2001) Pre-operative serum levels of sialyl Tn antigen predict liver metastasis and poor prognosis in patients with gastric cancer. Eur. J. Surg. Oncol. 27, 731-739
64. Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., and Seed, B. (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61, 1303-1313
65. Qiao, X. T., and Gumucio, D. L. (2011) Current molecular markers for gastric progenitor cells and gastric cancer stem cells. J. Gastroenterol. 46, 855-865
66. Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U., and Bell, J. I. (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. U.S.A. 89, 12160-12164
67. Orian-Rousseau, V. (2010) CD44, a therapeutic target for metastasising tumours. Eur. J. Cancer 46, 1271-1277
68. Ten Hagen, K. G., Hagen, F. K., Balys, M. M., Beres, T. M., Van Wuyckhuyse, B., and Tabak, L. A. (1998) Cloning and expression of a novel, tissue specifically expressed member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family. J. Biol. Chem. 273, 27749-27754
69. Bennett, E. P., Mandel, U., Clausen, H., Gerken, T. A., Fritz, T. A., and Tabak, L. A. (2012) Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology 22, 736-756
70. He, H., Shen, Z., Zhang, H., Wang, X., Tang, Z., Xu, J., and Sun, Y. (2014) Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer. Br. J. Cancer 110, 2021-2029